Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice
Inverse metabolic engineering for improving protein content in Saccharomyces cerevisiae
Imad El Asmar , this FDA-approved treatment helps regulate appetite, improve metabolic health, and support long-term weight management
The FDA-approved finished products containing semaglutide and tirzepatide are administered via injection
Extracellular cysteine mutation was defined as a mutation that included at least one of the following cysteine residues: 609, 611, 618, 620, 630, or 634
DiStefano, PhD, MBE, assistant professor at the University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences